More SPAC Woes As One Vehicle Shutters, Another Deal Nixed
A Singaporean special-purpose acquisition company said it would shutter on Wednesday after failing to complete a merger, one day after psychedelic drug developer Filament Health Corp.'s plan to list in the...To view the full article, register now.
Already a subscriber? Click here to view full article